Penciclovir: Difference between revisions
No edit summary |
|||
| Line 26: | Line 26: | ||
'''| [[Penciclovir clinical studies|Clinical Studies]]''' | '''| [[Penciclovir clinical studies|Clinical Studies]]''' | ||
'''| [[Penciclovir dosage and administration|Dosage and Administration]]''' | '''| [[Penciclovir dosage and administration|Dosage and Administration]]''' | ||
'''| [[Penciclovir labels and packages|Labels and Packages]]''' | '''| [[Penciclovir labels and packages|Labels and Packages]]''' | ||
Revision as of 15:55, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Penciclovir (INN) (IPA: Template:IPA) is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections. It is a nucleoside analogue which exhibits low toxicity and good selectivity. Because penciclovir is absorbed poorly when given orally (by mouth) it is used more as a topical treatment, and is the active ingredient in the cold sore medications Denavir and Fenistil. Famciclovir is a prodrug of penciclovir with improved oral bioavailability.
Category
Anticiral
US Brand Names
DENAVIR®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | Labels and Packages